Inflammatory profile of oxidized phospholipids

Thrombosis and Haemostasis

Volumn 97, Issue 3, 2007, Pages 348-354

  Bochkov, Valery N ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial cells; Inflammation; Phospholipids

Indexed keywords

CHEMOKINE; CYTOKINE; OXIDIZED PHOSPHOLIPID; PHOSPHOLIPID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; CELL ADHESION; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; LIPID PEROXIDATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ATHEROSCLEROSIS; BLOOD COAGULATION; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LIPID PEROXIDATION; LYSOPHOSPHOLIPIDS; PHOSPHOLIPIDS; RECEPTORS, LYSOPHOSPHOLIPID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33947321122     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-08-0474     Document Type: Review

References (82)

1. Watson AD, Leitinger N, Navab M, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997; 272: 13597-13607.
2. Subbanagounder G, Leitinger N, Schwenke DC, et al. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position. Arterioscler Thromb Vasc Biol 2000; 20: 2248-2254.
3. Podrez EA, Poliakov E, Shen Z, et al. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions. J Biol Chem 2002; 277: 38517-38523.
4. Leitinger N. Oxidized phospholipids as triggers of inflammation in atherosclerosis. Mol Nutr Food Res 2005; 49: 1063-1071.
5. Bochkov VN, Kadl A, Huber J, et al. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Nature 2002; 419: 77-81.
6. Yoshimi N, Ikura Y, Sugama Y, et al. Oxidized phosphatidylcholine in alveolar macrophages in idiopathic interstitial pneumonias. Lung 2005; 183: 109-121.
7. Nakamura T, Henson PM, Murphy RC. Occurrence of oxidized metabolites of arachidonic acid esterified to phospholipids in murine lung tissue. Anal Biochem 1998; 262: 23-32.
8. Ikura Y, Ohsawa M, Suekane T, et al. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology 2006; 43: 506-514.
9. Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N EngI J Med 2005; 353: 46-57.
10. Huber J, Vales A, Mitulovic G, et al. Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol 2002; 22: 101-107.
11. Chang MK, Binder CJ, Miller YI, et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004; 200: 1359-1370.
12. Van Lenten BJ, Wagner AC, Navab M, et al. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation 2004; 110: 3252-3258.
13. Subbanagounder G, Wong JW, Lee H, et al. Epoxy-isoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1 beta. J Biol Chem 2002; 277: 7271-7281.
14. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 1995; 96: 2882-2891.
15. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990; 85: 1260-1266.
16. Kim JA, Territo MC, Wayner E, et al. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler Thromb 1994; 14: 427-433.
17. Shih PT, Elices MJ, Fang ZT, et al. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating betal integrin. J Clin Invest 1999; 103: 613-625.
18. Leitinger N, Tyner TR, Oslund L, et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci USA 1999; 96: 12010-12015.
19. Furnkranz A, Schober A, Bochkov VN, et al. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Thromb Vase Biol 2005; 25: 633-638.
20. Ramos CL, Huo Y, Jung U, et al. Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res 1999; 84: 1237-1244.
21. Shih PT, Brennan ML, Vora DK, et al. Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. Circ Res 1999; 84: 345-351.
22. Johnson RC, Chapman SM, Deng ZM, et al. Absence of P-selectin delays fatty streak formation in mice. J Clin Invest 1997; 99: 1037-1043.
23. Lee H, Shi W, Tontonoz P, et al. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 2000; 87: 516-521.
24. Subbanagounder G, Deng Y, Borromeo C, et al. Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells. Vascul Pharmacol 2002; 38: 201-209.
25. Reddy ST, Grijalva V, Ng C, et al. Identification of genes induced by oxidized phospholipids in human aortic endothelial cells. Vascul Pharmacol 2002; 38: 211-218.
26. Kadl A, Huber J, Gruber F, et al. Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS. Vascul Pharmacol 2002; 38: 219-27.
27. Gargalovic PS, Gharavi NM, Clark MJ, et al. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 2490-2496.
28. Huo Y, Weber C, Forlow SB, et al. The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. J Clin Invest 2001; 108: 1307-1314.
29. Rollins BJ. Chemokines and atherosclerosis: what Adam Smith has to say about vascular disease. J Clin Invest 2001; 108: 1269-1271.
30. Bochkov VN, Mechtcheriakova D, Lucerna M, et al. Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT. Blood 2002; 99: 199-206.
31. Ishii H, Tezuka T, Ishikawa H, et al. Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta-RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 2003; 101: 4765-4774.
32. Ohkura N, Hiraishi S, Itabe H, et al. Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. Antioxid Redox Signal 2004; 6: 705-712.
33. Marathe GK, Zimmerman GA, Prescott SM, et al. Activation of vascular cells by PAF-like lipids in oxidized LDL. Vascul Pharmacol 2002; 38: 193-200.
34. Gopfert MS, Siedler F, Siess W, et al. Structural identification of oxidized acyl-phosphatidylcholines that induce platelet activation. J Vasc Res 2005; 42: 120-132.
35. Rouhanizadeh M, Hwang J, Clempus RE, et al. Oxidized-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic Biol Med 2005; 39: 1512-1522.
36. Gharavi NM, Baker NA, Mouillesseaux KP, et al. Role of endothelial nitric oxide synthase in the regulation of SREBP activation by oxidized phospholipids. Circ Res 2006; 98: 768-76.
37. Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Biol 2005; 25: 923-931.
38. Tomura H, Mogi C, Sato K, et al. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi -functional receptors. Cell Signal 2005; 17: 1466-1476.
39. Anliker B, Chun J. Cell surface receptors in lysophospholipid signaling. Semin Cell Dev Biol 2004; 15: 457-465.
40. Siess W, Tigyi G. Thrombogenic and atherogenic activities of lysophosphatidic acid. J Cell Biochem 2004; 92: 1086-1094.
41. Tselepis AD, John Chapman M. Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. Atheroscler Suppl 2002; 3: 57-68.
42. Marathe GK, Prescott SM, Zimmerman GA, et al. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc Med 2001; 11: 139-142.
43. Marathe GK, Davies SS, Harrison KA, et al. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. J Biol Chem 1999; 274: 28395-28404.
44. Li R, Mouillesseaux KP, Montoya D, et al. Identification of prostaglandin E2 receptor subtype 2 as a receptor activated by OxPAPC. Circ Res 2006; 98: 642-650.
45. Davies SS, Pontsler AV, Marathe GK, et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J Biol Chem 2001; 276: 16015-16023.
46. Delerive P, Furman C, Teissier E, et al. Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner. FEBS Lett 2000; 471: 34-38.
47. Miller YI, Viriyakosol S, Worrall DS, et al. Toll-like receptor 4-dependent and -independent cytokine secretion induced by minimally oxidized low-density lipoprotein in macrophages. Arterioscler Thromb Vasc Biol 2005; 25: 1213-1219.
48. Walton KA, Hsieh X, Gharavi N, et al. Receptors involved in the oxidized 1-palmitoyl-2-arachidonoylsn-glycero-3-phosphorylcholine-mediated synthesis of interleukin-8. A role for Toll-like receptor 4 and a of glycosylphosphatidylinositol-anchored protein. J Biol Chem 2003; 278: 29661-29666.
49. Chang MK, Binder CJ, Torzewski M, et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 2002; 99: 13043-13048.
50. Podrez EA, Poliakov E, Shen Z, et al. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J Biol Chem 2002; 277: 38503-38516.
51. Boullier A, Gillotte KL, Horkko S, et al. The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein. J Biol Chem 2000; 275: 9163-9169.
52. Gillotte-Taylor K, Boullier A, Witztum JL, et al. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res 2001; 42: 1474-1482.
53. Yeh M, Cole AL, Choi J, et al. Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res 2004; 95: 780-788.
54. Gargalovic PS, Imura M, Zhang B, et al. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc Natl Acad Sci USA 2006; 103: 12741-12746.
55. Brame CJ, Boutaud O, Davies SS, et al. Modification of proteins by isoketal-containing oxidized phospholipids. J Biol Chem 2004; 279: 13447-13451.
56. Cole AL, Subbanagounder G, Mukhopadhyay S, et al. Oxidized phospholipid-induced endothelial cell/monocyte interaction is mediated by a cAMP-dependent R-Ras/P13-kinase pathway. Arterioscler Thromb Vasc Biol 2003; 23: 1384-1390.
57. Yeh M, Gharavi NM, Choi J, et al. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 2004; 279: 30175-30181.
58. Kronke G, Bochkov VN, Huber J, et al. Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem 2003; 278: 51006-51014.
59. Yeh M, Leitinger N, de Martin R, et al. Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001; 21: 1585-1591.
60. Walton KA, Cole AL, Yeh M, et al. Specific phospholipid oxidation products inhibit ligand activation of toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol 2003; 23: 1197-1203.
61. Ma Z, Li J, Yang L, et al. Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2004; 286: L808-816.
62. Walton KA, Gugiu BG, Thomas M, et al. A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products. J Lipid Res 2006; 47: 1967-1974.
63. Loidl A, Sevcsik E, Riesenhuber G, et al. Oxidized phospholipids in minimally modified low density lipoprotein induce apoptotic signaling via activation of acid sphingomyelinase in arterial smooth muscle cells. J Biol Chem 2003; 278: 32921-8.
64. Ghersa P, Hooft van Huijsduijnen R, Whelan J, et al. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 1994; 269: 29129-29137.
65. Rahman A, Anwar KN, Minhajuddin M, et al. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-kappaB activation and ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1017-1024.
66. Takahashi N, Tetsuka T, Uranishi H, et al. Inhibition of the NF-kappaB transcriptional activity by protein kinase A. Eur J Biochem 2002; 269: 4559-65.
67. Fasshauer M, Klein J, Lossner U, et al. Isoproterenol is a positive regulator of the suppressor of cytokine signaling-3 gene expression in 3T3-Ll adipocytes. J Endocrinol 2002; 175: 727-733.
68. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 2003; 54: 469-487.
69. Parry GC, Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol 1997; 159: 5450-5456.
70. Delerive P, De Bosscher K, Besnard S, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999; 274:32048-32054.
71. Chapman NR, Perkins ND. Inhibition of the Re1A(p65) NF-kappaB subunit by Egr-1. J Biol Chem 2000; 275: 4719-4725.
72. Birukov KG, Bochkov VN, Birukova AA, et al. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 2004; 95: 892-901.
73. Nonas S, Miller I, Kawkitinarong K, et al. Oxidized phospholipids reduce vascular leak and inflammation in rat model of acute lung injury. Am J Respir Crit Care Med 2006; 173: 1130-1138.
74. Birukov KG. Oxidized lipids: the two faces of vascular inflammation. Curr Atheroscler Rep 2006; 8: 223-231.
75. Alcaraz MJ, Fernandez P, Guillen MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des 2003; 9: 2541-2551.
76. Hoekstra KA, Godin DV, Cheng KM. Protective role of heme oxygenase in the blood vessel wall during atherogenesis. Biochem Cell Biol 2004; 82: 351-359.
77. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-428.
78. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-1026.
79. Ishikawa K, Navab M, Leitinger N, et al. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997; 100: 1209-1216.
80. Bochkov VN, Philippova M, Oskolkova O, et al. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ Res 2006; 99: 900-908.
81. Friedman P, Horkko S, Steinberg D, et al. Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol concentration. J Biol Chem 2002; 277: 7010-7020.
82. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469-478.